Meghan N. Feldpausch

1.5k total citations
30 papers, 599 citations indexed

About

Meghan N. Feldpausch is a scholar working on Emergency Medicine, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Meghan N. Feldpausch has authored 30 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Emergency Medicine, 10 papers in Epidemiology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Meghan N. Feldpausch's work include HIV-related health complications and treatments (16 papers), Liver Disease Diagnosis and Treatment (8 papers) and HIV Research and Treatment (6 papers). Meghan N. Feldpausch is often cited by papers focused on HIV-related health complications and treatments (16 papers), Liver Disease Diagnosis and Treatment (8 papers) and HIV Research and Treatment (6 papers). Meghan N. Feldpausch collaborates with scholars based in United States, Canada and Puerto Rico. Meghan N. Feldpausch's co-authors include Steven Grinspoon, Martin Torriani, Hang Lee, Takara L. Stanley, Lindsay T. Fourman, Hideo Makimura, Colleen Hadigan, Isabel Zheng, Raymond T. Chung and David E. Kleiner and has published in prestigious journals such as JAMA, The Journal of Clinical Endocrinology & Metabolism and Clinical Infectious Diseases.

In The Last Decade

Meghan N. Feldpausch

29 papers receiving 594 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meghan N. Feldpausch United States 13 223 212 211 120 114 30 599
Jacqueline Capeau France 11 289 1.3× 106 0.5× 148 0.7× 44 0.4× 143 1.3× 14 559
Jean Philippe Bastard France 9 348 1.6× 85 0.4× 54 0.3× 236 2.0× 126 1.1× 9 747
Cristiane Valle Tovo Brazil 17 516 2.3× 76 0.4× 49 0.2× 34 0.3× 72 0.6× 69 696
Gabriella Di Lorenzo Italy 12 396 1.8× 22 0.1× 173 0.8× 94 0.8× 84 0.7× 14 751
Jesús Castillo Spain 13 522 2.3× 130 0.6× 52 0.2× 194 1.6× 103 0.9× 26 872
Maurizio Soldini Italy 11 246 1.1× 47 0.2× 63 0.3× 55 0.5× 84 0.7× 22 472
Bryan Wai United States 16 78 0.3× 97 0.5× 139 0.7× 332 2.8× 100 0.9× 26 675
Birgitte Mørn Denmark 6 57 0.3× 36 0.2× 55 0.3× 150 1.3× 31 0.3× 11 376
Luciano Restivo Italy 7 491 2.2× 69 0.3× 31 0.1× 51 0.4× 43 0.4× 11 671
Eduardo Albéniz Spain 13 122 0.5× 28 0.1× 29 0.1× 16 0.1× 385 3.4× 46 779

Countries citing papers authored by Meghan N. Feldpausch

Since Specialization
Citations

This map shows the geographic impact of Meghan N. Feldpausch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meghan N. Feldpausch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meghan N. Feldpausch more than expected).

Fields of papers citing papers by Meghan N. Feldpausch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meghan N. Feldpausch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meghan N. Feldpausch. The network helps show where Meghan N. Feldpausch may publish in the future.

Co-authorship network of co-authors of Meghan N. Feldpausch

This figure shows the co-authorship network connecting the top 25 collaborators of Meghan N. Feldpausch. A scholar is included among the top collaborators of Meghan N. Feldpausch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meghan N. Feldpausch. Meghan N. Feldpausch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Srinivasa, Suman, et al.. (2021). Coronary Vasculature and Myocardial Structure in HIV: Physiologic Insights From the Renin-Angiotensin-Aldosterone System. The Journal of Clinical Endocrinology & Metabolism. 106(12). 3398–3412. 6 indexed citations
3.
Fourman, Lindsay T., Takara L. Stanley, James M. Billingsley, et al.. (2021). Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach. Scientific Reports. 11(1). 10485–10485. 7 indexed citations
4.
Stanley, Takara L., Lindsay T. Fourman, Isabel Zheng, et al.. (2020). Relationship of IGF-1 and IGF-Binding Proteins to Disease Severity and Glycemia in Nonalcoholic Fatty Liver Disease. The Journal of Clinical Endocrinology & Metabolism. 106(2). e520–e533. 76 indexed citations
5.
Côté, Hélène C. F., et al.. (2020). Relationship of Telomere Length to Fat Redistribution in HIV. Open Forum Infectious Diseases. 7(12). ofaa523–ofaa523. 2 indexed citations
6.
Fourman, Lindsay T., James M. Billingsley, Shannan J. Ho Sui, et al.. (2020). Effects of tesamorelin on hepatic transcriptomic signatures in HIV-associated NAFLD. JCI Insight. 5(16). 19 indexed citations
7.
Srinivasa, Suman, Martin Torriani, Kathleen V. Fitch, et al.. (2019). Brief Report: Adipogenic Expression of Brown Fat Genes in HIV and HIV-Related Parameters. JAIDS Journal of Acquired Immune Deficiency Syndromes. 82(5). 491–495. 8 indexed citations
8.
Stanley, Takara L., Lindsay T. Fourman, Meghan N. Feldpausch, et al.. (2019). Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial. The Lancet HIV. 6(12). e821–e830. 59 indexed citations
9.
Fourman, Lindsay T., Jane Hubbard, Tara M. Holmes, et al.. (2019). Comparison of visceral fat measurement by dual-energy X-ray absorptiometry to computed tomography in HIV and non-HIV. Nutrition and Diabetes. 9(1). 6–6. 18 indexed citations
10.
Srinivasa, Suman, Kathleen V. Fitch, Tricia H. Burdo, et al.. (2018). Significant Association of Aldosterone and Liver Fat Among HIV-Infected Individuals With Metabolic Dysregulation. Journal of the Endocrine Society. 2(10). 1147–1157. 10 indexed citations
11.
Fourman, Lindsay T., Meghan N. Feldpausch, Jean‐Claude Mamputu, et al.. (2017). Visceral fat reduction with tesamorelin is associated with improved liver enzymes in HIV. AIDS. 31(16). 2253–2259. 10 indexed citations
12.
Feldpausch, Meghan N., et al.. (2017). Fibroblast growth factor 21 decreases after liver fat reduction via growth hormone augmentation. Growth Hormone & IGF Research. 37. 1–6. 7 indexed citations
13.
Toribio, Mabel, Min Hi Park, Markella V. Zanni, et al.. (2017). HDL Cholesterol Efflux Capacity in Newly Diagnosed HIV and Effects of Antiretroviral Therapy. The Journal of Clinical Endocrinology & Metabolism. 102(11). 4250–4259. 9 indexed citations
14.
Fitch, Kathleen V., Meghan N. Feldpausch, & Sara E. Looby. (2016). Biomarkers and Clinical Indices of Aging with HIV. PubMed. 42. 47–58. 6 indexed citations
15.
Makimura, Hideo, Takara L. Stanley, Ana Luísa De Sousa‐Coelho, et al.. (2015). Metabolic Effects of Long-Term Reduction in Free Fatty Acids With Acipimox in Obesity: A Randomized Trial. The Journal of Clinical Endocrinology & Metabolism. 101(3). 1123–1133. 23 indexed citations
17.
Stanley, Takara L., Meghan N. Feldpausch, Jin-Hee Oh, et al.. (2014). Effect of Tesamorelin on Visceral Fat and Liver Fat in HIV-Infected Patients With Abdominal Fat Accumulation. JAMA. 312(4). 380–380. 61 indexed citations
18.
Makimura, Hideo, Caitlin A. Murphy, Meghan N. Feldpausch, & Steven Grinspoon. (2013). The Effects of Tesamorelin on Phosphocreatine Recovery in Obese Subjects With Reduced GH. The Journal of Clinical Endocrinology & Metabolism. 99(1). 338–343. 9 indexed citations
19.
Stanley, Takara L., Meghan N. Feldpausch, Caitlin A. Murphy, Steven Grinspoon, & Hideo Makimura. (2013). Discordance of IGF-1 and GH stimulation testing for altered GH secretion in obesity. Growth Hormone & IGF Research. 24(1). 10–15. 10 indexed citations
20.
Makimura, Hideo, et al.. (2011). Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle size. Clinical Endocrinology. 76(2). 220–227. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026